ArticleMolecules (Basel, Switzerland)2026
GNN-MA: Soft Molecular Alignment with Cross-Graph Attention for Ligand-Based Virtual Screening.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ligand-based virtual screening (LBVS) seeks strong early enrichment when searching ultra-large libraries, but practical screening often relies on 1D/2D descriptions while 3D information is expensive and uncertain due to conformer generation and alignment. We propose GNN-MA, a retrieval-style pairwise scoring model for query-candidate molecular pairs that uses molecular graphs as a unified representation. Built on intra-graph message passing, GNN-MA adds cross-graph attention to learn atom-level soft alignment that focuses on key substructures relevant to activity matching, and introduces a bond-to-atom semantic aggregation module to better exploit chemical bond cues for similarity scoring. The framework uses 2D molecular graphs derived from SMILES for retrieval-style matching and does not rely on explicit 3D conformational modeling or alignment. Experiments on DUD-E and LIT-PCBA show that GNN-MA achieves competitive overall discrimination (ROC-AUC) and, relative to its ablated variants, provides consistent gains in early-enrichment metrics (EF@1-5%) on DUD-E, while on LIT-PCBA the improvements are more target-dependent. The learned atom-level soft alignment also provides a qualitative interpretability cue in case studies. Throughput benchmarks suggest that GNN-MA is most suitable as a re-ranking/refinement model after a fast prefiltering stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.